Skip to main content
Affordable Employee Training Exclusively for NJBIA Members LEARN MORE

Curexa Pharmacy, a leading national pharmacy based in Egg Harbor Township, announced Thursday that Robert Cimorelli has been named its new senior vice president of Regulatory and Strategic Operations. 

Cimorelli brings extensive expertise in pharmaceutical research, product development, quality assurance, regulatory affairs, strategic planning, and operations, the company said. His compounding proficiency spans sterile and non-sterile processes for human and veterinary markets, including nuclear medicine. 

Curexa, an API-connected 503A compounding pharmacy, partners with direct-to-consumer telemedicine wellness brands to offer customized pharmaceutical products. Cimorelli’s background with The Ritedose Corporation, Boothwyn Pharmacy, and Pentec Health uniquely positions him to drive growth in the 503A and 503B compounding markets, the company said. 

Cimorelli has been pivotal in applying Quality by Design and Total Quality Management principles to navigate regulations, improve operations, and lead product development and quality assurance, Curexa said in its Feb. 22 announcement. 

Mark K. Taylor, RPh. MBA, president, and CEO of Curexa, said he was excited that Cimorelli has joined the Curexa team. 

“Robert’s extensive experience in 503a and 503b compounding brings valuable insights to our executive team, reinforcing our commitment to patient safety with his expertise in compounding and FDA compliance,” Taylor said. 

John Pouschine, board chairman and managing member of Pouschine Cook Capital, a significant shareholder of Curexa,  said Cimorelli will be instrumental in designing and constructing cutting-edge facilities to enhance service for customers amid Curexa’s rapid expansion. 

Originally from Philadelphia, Cimorelli holds a Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy and Science. He also completed professional certificates in Executive Leadership Principles and Drug and Medical Device Development from the Massachusetts Institute of Technology (MIT). 

Cimorelli is a licensed pharmacist in 15 states and a member of the International Society of Pharmaceutical Engineering. 

About Curexa 

Founded in 2003, Curexa Pharmacy has become a leading provider of compounding, packaging, labeling, and digital and traditional pharmacy solutions for telemedicine and medical providers, veterinarians, manufacturers, and clinical research organizations across the nation. Curexa’s broad range of services includes pre-launch support, customized formulations, API integration, packaging/branding, and pharmacy regulatory compliance.